Survanta Intratracheal is a lung surface acting agent, or "surfactant." It helps the lungs function normally. This medicine is similar to the natural fluid in the lungs that helps maintain effective breathing.

Survanta Intratracheal is used to treat or prevent respiratory distress syndrome (RDS) in a premature baby whose lungs have not fully developed.

Survanta Intratracheal may also be used for purposes not listed in this medication guide.

Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.

Survanta Intratracheal is given directly into the baby's lungs through a breathing tube that is also connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).

Your baby will remain under constant supervision during treatment with Survanta Intratracheal.

Follow your doctor's instructions about any restrictions on feeding or other medications after your child has been treated with Survanta Intratracheal.

Survanta Intratracheal is given directly into the baby's lungs through a breathing tube. Your baby will receive this medication in a neonatal intensive care unit (NICU) or similar hospital setting.

The breathing tube is connected to a ventilator (a machine that moves air in and out of the lungs to help your baby breathe easier and get enough oxygen).

Survanta Intratracheal is given as soon as possible after the baby's birth, usually within minutes or hours.

Your baby's breathing, blood pressure, oxygen levels, and other vital signs will be watched closely during treatment with Survanta Intratracheal. This will help your doctor determine how long to continue treatment with this medicine. Your child may also need blood tests.

What happens if my child misses a dose?

Since Survanta Intratracheal is given as needed by a healthcare professional, it is not likely that your baby will miss a dose.

To best participate in the care of your baby while he or she is in the NICU, carefully follow all instructions provided by your baby's caregivers.

Since Survanta Intratracheal is given in a controlled medical setting by a healthcare professional, an overdose is not likely to occur. However, an overdose of beractant is not expected to produce life-threatening symptoms.

Follow your doctor's instructions about any restrictions in feeding, medications, or activity after your baby has been treated with Survanta Intratracheal.

There is a possibility that the baby will have breathing difficulties during the Survanta Intratracheal treatment, and these problems may require further treatment by health care professionals. Your baby will remain under constant supervision during treatment with this medicine.

Tell your child's caregivers at once if the child has any of these serious side effects:

• pale skin;

• slow heartbeat;

• breathing that stops;

• urinating less than usual; or

• blood in the urine.

Less serious side effects include:

• noisy breathing;

• feeding or bowel problems; or

• bleeding around the endotracheal tube.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Your baby's caregivers will manage and monitor all medications given to your baby during treatment in the NICU. A drug interaction between Survanta Intratracheal and other medications is not expected to occur.

Do not give any medications to your baby that have not been prescribed by the baby's doctor. This includes vitamins, minerals, or herbal products.